Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen China Nuclear Huidewei Biotechnology is a specialized medical diagnostics company based in China, focusing on the detection of Helicobacter pylori (Hp) infections. As a subsidiary of Shenzhen Zhonghe Headway Bio-Sci & Tech, the company develops and manufactures urea breath test (UBT) kits utilizing carbon-13 and carbon-14 isotopes. Its comprehensive diagnostic solutions include both the labeled urea reagents and the high-precision breath analyzers, such as infrared spectrometers and liquid scintillation counters. The company's products are widely implemented in clinical settings for non-invasive gastric screening and post-treatment monitoring. Leveraging the nuclear technology background of its parent organizations, Huidewei maintains a significant presence in the domestic Chinese diagnostic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen China Nuclear Huidewei Biotechnology.